$XAIR
Beyond Air, Inc. Stock $xair

$xair Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223004156 Filed on February 10, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$0.00
YoY Change
Cost Of Revenue	$310.0K	$68.00K
YoY Change
Gross Profit	-$310.0K	-$68.00K
YoY Change
Gross Profit Margin
Selling, General & Admin	$9.550M	$8.941M	$4.943M
YoY Change	53.54%	80.88%	100.12%
% of Gross Profit
Research & Development	$4.130M	$5.000M	$2.543M
YoY Change	11.29%	96.62%	-22.71%
% of Gross Profit
Depreciation & Amortization	$246.0K	$256.0K	$80.00K
YoY Change	89.23%	220.0%	14.29%
% of Gross Profit
Operating Expenses	$13.67M	$13.94M	$7.486M
YoY Change	37.65%	86.23%	29.74%
Operating Profit	-$13.98M	-$14.01M	-$7.486M
YoY Change		87.15%
Interest Expense	$770.0K	$46.00K	-$65.00K
YoY Change	-242.59%	-170.77%	-56.67%
% of Operating Profit
Other Income/Expense, Net	-$320.0K	$211.0K	-$411.0K
YoY Change	-32100.0%	-151.34%
Pretax Income	-$21.15M	-$13.80M	-$7.962M
YoY Change	2.36%	73.31%	37.99%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$20.17M	-$12.75M	-$7.739M
YoY Change	0.83%	64.71%	34.12%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.43	-$0.29
Diluted Earnings Per Share	-$0.67	-$0.43	-$288.5K
COMMON SHARES
Basic Shares Outstanding	30.09M shares	29.92M shares	26.82M shares
Diluted Shares Outstanding		29.92M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.88M	$53.12M	$83.47M
YoY Change	-42.82%	-36.36%	279.06%
Cash & Equivalents	$29.16M	$25.48M	$83.47M
Short-Term Investments	$16.72M	$27.64M
Other Short-Term Assets	$11.75M	$11.36M	$10.39M
YoY Change	-2.9%	9.34%	918.92%
Inventory	$1.129M	$955.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$59.41M	$66.02M	$94.68M
YoY Change	-36.08%	-30.28%	310.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.003M	$3.624M	$4.071M
YoY Change	150.78%	-10.98%	210.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$212.0K	$211.0K	$210.0K
YoY Change	2.42%	0.48%	425.0%
Total Long-Term Assets	$9.339M	$7.944M	$4.627M
YoY Change	49.33%	71.69%	165.92%
TOTAL ASSETS
Total Short-Term Assets	$59.41M	$66.02M	$94.68M
Total Long-Term Assets	$9.339M	$7.944M	$4.627M
Total Assets	$68.75M	$73.96M	$99.31M
YoY Change	-30.7%	-25.53%	300.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.016M	$1.411M	$1.611M
YoY Change	78.57%	-12.41%	32.05%
Accrued Expenses	$16.61M	$9.777M	$4.567M
YoY Change	98.39%	114.08%	200.46%
Deferred Revenue
YoY Change
Short-Term Debt	$695.0K	$60.00K	$0.00
YoY Change	-25.03%
Long-Term Debt Due	$80.00K
YoY Change
Total Short-Term Liabilities	$19.78M	$11.60M	$6.178M
YoY Change	84.65%	87.71%	113.77%
LONG-TERM LIABILITIES
Long-Term Debt	$120.0K	$140.0K	$200.0K
YoY Change	-40.0%	-30.0%	-95.5%
Other Long-Term Liabilities	$6.821M	$6.782M	$2.162M
YoY Change	-32.32%	213.69%	672.14%
Total Long-Term Liabilities	$6.941M	$6.922M	$2.362M
YoY Change	-32.47%	193.06%	-49.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.78M	$11.60M	$6.178M
Total Long-Term Liabilities	$6.941M	$6.922M	$2.362M
Total Liabilities	$26.72M	$18.52M	$14.32M
YoY Change	27.3%	29.35%	88.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$179.5M	-$159.3M
YoY Change	45.18%
Common Stock	$3.000K	$3.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$25.00K	$25.00K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$37.92M	$50.95M	$84.99M
YoY Change
Total Liabilities & Shareholders Equity	$68.75M	$73.96M	$99.31M
YoY Change	-30.7%	-25.53%	300.12%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$20.17M	-$12.75M	-$7.739M
YoY Change	0.83%	64.71%	34.12%
Depreciation, Depletion And Amortization	$246.0K	$256.0K	$80.00K
YoY Change	89.23%	220.0%	14.29%
Cash From Operating Activities	-$8.440M	-$8.510M	-$6.337M
YoY Change	6.85%	34.29%	20.48%
INVESTING ACTIVITIES
Capital Expenditures	$2.022M	$634.0K	-$419.0K
YoY Change	-691.23%	-251.31%	199.29%
Acquisitions
YoY Change
Other Investing Activities	$10.88M	$5.022M	$0.00
YoY Change	362633.33%
Cash From Investing Activities	$8.860M	$4.388M	-$419.0K
YoY Change	-2713.57%	-1147.26%	199.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$200.0K
YoY Change
Cash From Financing Activities	3.409M	-310.0K	50.71M
YoY Change	-39.86%	-100.61%	789.72%
NET CHANGE
Cash From Operating Activities	-8.440M	-8.510M	-6.337M
Cash From Investing Activities	8.860M	4.388M	-419.0K
Cash From Financing Activities	3.409M	-310.0K	50.71M
Net Change In Cash	3.829M	-4.432M	43.96M
YoY Change	-248.99%	-110.08%	14552.67%
FREE CASH FLOW
Cash From Operating Activities	-$8.440M	-$8.510M	-$6.337M
Capital Expenditures	$2.022M	$634.0K	-$419.0K
Free Cash Flow	-$10.46M	-$9.144M	-$5.918M
YoY Change	38.44%	54.51%	15.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30091307	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25478000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80242000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	27641000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10085000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	9988000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	955000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	350000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	355000	usd
CY2022Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	322000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1500000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2044000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	66015000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	92945000	usd
CY2022Q4	XAIR	Licensed Right To Use Technology LicensedRightToUseTechnology	1683000	usd
CY2022Q1	XAIR	Licensed Right To Use Technology LicensedRightToUseTechnology	1837000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2426000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1995000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	211000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	207000	usd
CY2022Q4	us-gaap	Assets Assets	73959000	usd
CY2022Q1	us-gaap	Assets Assets	99199000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1411000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001641631
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2021Q4	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2021Q4	XAIR	Estimated Liability For Contingent Loss EstimatedLiabilityForContingentLoss		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent		usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
CY2022Q4	XAIR	Issuance Of Common Stock Upon Vesting Of Restricted Stock Unit IssuanceOfCommonStockUponVestingOfRestrictedStockUnit		usd
CY2021Q3	XAIR	Stock Issued During Period Value Exerciseof Warrants StockIssuedDuringPeriodValueExerciseofWarrants		usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Provision For Other Losses ProvisionForOtherLosses		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	XAIR	Proceeds From Issuance Of Common Stock In Connection With Purchase Agreement ProceedsFromIssuanceOfCommonStockInConnectionWithPurchaseAgreement		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	XAIR	Accelerated Amortization Of Debt Discount Costs On Retirement Of Debt AcceleratedAmortizationOfDebtDiscountCostsOnRetirementOfDebt		usd
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1129000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9777000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8374000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	349000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	281000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	60000	usd
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent	927000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11597000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10712000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2282000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2079000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	140000	usd
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	200000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	4500000	usd
CY2022Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	8000000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18519000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	20990000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30013907	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38892
	dei	Entity Registrant Name EntityRegistrantName	BEYOND AIR, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3812456
	dei	Entity Address Address Line1 EntityAddressAddressLine1	900 Stewart Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 301
	dei	Entity Address City Or Town EntityAddressCityOrTown	Garden City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11530
	dei	City Area Code CityAreaCode	516
	dei	Local Phone Number LocalPhoneNumber	665-8200
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	XAIR
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30013907	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29886173	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29886173	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2216000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3624000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	25000	usd
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	25000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	210097000	usd
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-412000	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	196269000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159288000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123639000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	159000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	96000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	50946000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	72704000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4494000	usd
CY2022Q1	us-gaap	Minority Interest MinorityInterest	5505000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	55440000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	78209000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	73959000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	99199000	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	68000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	247000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	-68000	usd
	us-gaap	Gross Profit GrossProfit	-247000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5000000	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2543000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12679000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8091000	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8941000	usd
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4943000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25144000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12188000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	13941000	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	7486000	usd
	us-gaap	Operating Expenses OperatingExpenses	37823000	usd
	us-gaap	Operating Expenses OperatingExpenses	20279000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-14010000	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-7486000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38070000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20279000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	46000	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	57000	usd
	us-gaap	Interest Expense InterestExpense	142000	usd
	us-gaap	Interest Expense InterestExpense	377000	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	286000	usd
CY2021Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-8000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-108000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2000	usd
CY2022Q4	XAIR	Estimated Liability For Contingent Loss EstimatedLiabilityForContingentLoss	-248000	usd
	XAIR	Estimated Liability For Contingent Loss EstimatedLiabilityForContingentLoss	-248000	usd
	XAIR	Estimated Liability For Contingent Loss EstimatedLiabilityForContingentLoss	-2742000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	219000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	317000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	211000	usd
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-476000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-180000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3118000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-13798000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-6743000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-7962000	usd
	us-gaap	Profit Loss ProfitLoss	-38250000	usd
	us-gaap	Profit Loss ProfitLoss	-23397000	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1051000	usd
CY2021Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-223000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2601000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-223000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-12747000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-7739000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35649000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23174000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-184000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	159000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12931000	usd
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7739000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-35490000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-23174000	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29921254	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26822302	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29902694	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24319771	shares
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	78209000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4624000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	172000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-11654000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	71351000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	71351000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	214000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4714000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	171000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-12797000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63652000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63652000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5866000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-280000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-13798000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	55440000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30464000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7482000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1031000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1216000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33450000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33450000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14958000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1155000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-8692000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40921000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40921000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14049000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10107000	usd
CY2021Q4	XAIR	Stock Issued During Period Value Exerciseof Warrants StockIssuedDuringPeriodValueExerciseofWarrants	1391000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	149000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2116000	usd
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	1100000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	30000000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-7962000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	90771000	usd
	us-gaap	Profit Loss ProfitLoss	-38250000	usd
	us-gaap	Profit Loss ProfitLoss	-23397000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	439000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	193000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	154000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	29000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15204000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4487000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	528000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	237000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	166000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	38000	usd
	XAIR	Foreign Currency Adjustments ForeignCurrencyAdjustments	144000	usd
	XAIR	Foreign Currency Adjustments ForeignCurrencyAdjustments	-7000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	235000	usd
	us-gaap	Provision For Other Losses ProvisionForOtherLosses	49000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	33000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-233000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	607000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-491000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	254000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-338000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	286000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2256000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2501000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24569000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15234000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	32777000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5188000	usd
	XAIR	Payments To Security Deposits Made On Operating Leases PaymentsToSecurityDepositsMadeOnOperatingLeases	4000	usd
	XAIR	Payments To Security Deposits Made On Operating Leases PaymentsToSecurityDepositsMadeOnOperatingLeases	73000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1855000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1038000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	77400	shares
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29447000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1111000	usd
	XAIR	Proceeds From Issuance Of Common Stock In Connection With Purchase Agreement ProceedsFromIssuanceOfCommonStockInConnectionWithPurchaseAgreement	11138000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	214000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	36489000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1391000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25200000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	199000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	927000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	635000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-713000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	73783000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	63000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54667000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	57439000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	90230000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35268000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35563000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	92707000	usd
	XAIR	Rightofuse Assets RightofuseAssets	466000	usd
	XAIR	Rightofuse Assets RightofuseAssets	602000	usd
	XAIR	Operating Lease Liabilities OperatingLeaseLiabilities	466000	usd
	XAIR	Operating Lease Liabilities OperatingLeaseLiabilities	602000	usd
	XAIR	Accelerated Amortization Of Debt Discount Costs On Retirement Of Debt AcceleratedAmortizationOfDebtDiscountCostsOnRetirementOfDebt	390000	usd
	us-gaap	Interest Paid Net InterestPaidNet	25000	usd
	us-gaap	Interest Paid Net InterestPaidNet	334000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	87000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	68000	usd
CY2022Q4	XAIR	Accrued Agreement AccruedAgreement	1500000	usd
CY2022Q1	XAIR	Accrued Agreement AccruedAgreement	1500000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	169000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zYX9u4c5gJqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zcyO58dM6E1c">Reclassifications</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zCCobEzMdZ8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z92K4zvXkB5h">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its significant estimates including accruals for expenses under consulting, licensing agreements, and clinical trials, stock-based compensation, contingency recognition and the determination of deferred tax attributes and the valuation allowance thereon.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24600000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159300000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	10100000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	10000000.0	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7400000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25478000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80242000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10085000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	9988000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35563000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	90230000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	27641000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	63204000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	90230000	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	82000	usd
CY2022Q4	XAIR	Total Shortterm Accrued Expense TotalShorttermAccruedExpense	9777000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	27641000	usd
	XAIR	Marketable Securities Current Unrealized Loss MarketableSecuritiesCurrentUnrealizedLoss	38000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2022Q2	XAIR	Tax Rebate TaxRebate	182000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	949600	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	6.92
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	180100	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	6.39
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	769500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.04
CY2022Q4	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	588000	usd
CY2021Q4	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	930000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1983000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1249000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4684000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2762000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1059000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	767000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3624000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1995000	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	204000	usd
CY2021Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	70000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	439000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	193000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	5866000	usd
CY2021Q4	us-gaap	Share Based Compensation ShareBasedCompensation	2116000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15204000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4487000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	460520	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.08
CY2022Q4	XAIR	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Intrinsic Value ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1IntrinsicValue	352	usd
CY2022Q1	XAIR	Total Shortterm Accrued Expense TotalShorttermAccruedExpense	8374000	usd
CY2022Q4	XAIR	Accrued Settlement Payments Due AccruedSettlementPaymentsDue	4500000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1500000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2044000	usd
CY2022Q4	XAIR	Vendors Research And Development VendorsResearchAndDevelopment	522000	usd
CY2022Q1	XAIR	Vendors Research And Development VendorsResearchAndDevelopment	1006000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	226000	usd
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	442000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1058000	usd
CY2022Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	409000	usd
CY2022Q4	XAIR	Accruals For Contingent Liabilities AccrualsForContingentLiabilities	2803000	usd
CY2022Q1	XAIR	Accruals For Contingent Liabilities AccrualsForContingentLiabilities	2435000	usd
CY2022Q4	XAIR	Accrued Settlement AccruedSettlement	3500000	usd
CY2022Q1	XAIR	Accrued Settlement AccruedSettlement	2500000	usd
CY2022Q1	XAIR	Accrued Settlement Payments Due AccruedSettlementPaymentsDue	8000000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	4500000	usd
CY2022Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	8000000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6875151	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6926462	shares
CY2021Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	10500000	usd
CY2021Q2	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	6000000	usd
CY2022Q4	XAIR	Outstanding Amount Under Purchase OutstandingAmountUnderPurchase	4100000	usd
CY2021Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	5800000	usd
CY2021Q4	XAIR	Collateral Amount CollateralAmount	7400000	usd
CY2021Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2400000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	2600000	usd
CY2021Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2600000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	200000	usd
CY2021Q4	XAIR	Amount Of Terminated Loan AmountOfTerminatedLoan	4800000	usd

Files In Submission

Name	View Source	Status
0001493152-23-004156-index-headers.html	Edgar Link	pending
0001493152-23-004156-index.html	Edgar Link	pending
0001493152-23-004156.txt	Edgar Link	pending
0001493152-23-004156-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xair-20221231.xsd	Edgar Link	pending
xair-20221231_cal.xml	Edgar Link	unprocessable
xair-20221231_def.xml	Edgar Link	unprocessable
xair-20221231_lab.xml	Edgar Link	unprocessable
xair-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XAIR
Beyond Air, Inc. Stock $xair

2023 Q1 Form 10-Q Financial Statement

#000149315223004156 Filed on February 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XAIR Beyond Air, Inc. Stock $xair

2023 Q1 Form 10-Q Financial Statement

#000149315223004156 Filed on February 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XAIR
Beyond Air, Inc. Stock $xair